Case Details
- Citation: [2024] SGHC 170
- Court: High Court (General Division)
- Originating Claim No: OC 301 of 2022
- Companies Winding Up No: CWU 195 of 2022
- Title: Oon Swee Gek & 2 Ors v Violet Oon Inc Pte Ltd & 2 Ors
- Judgment Type: Supplementary judgment
- Date: 23 May 2024 (judgment reserved); 3 July 2024 (judgment date shown in extract)
- Judge: Philip Jeyaretnam J
- Plaintiffs/Claimants: Oon Swee Gek; Tay Su-Lyn; Tay Yiming
- Defendants/Respondents: Violet Oon Inc Pte Ltd; Murjani Manoj Mohan; Group MMM Pte Ltd
- Legal Areas: Company law; oppression remedies; share buy-out valuation; costs in commercial litigation
- Statutes Referenced: Insolvency, Restructuring and Dissolution Act 2018; Companies Act 1967 (2020 Rev Ed)
- Key Provisions Mentioned in Extract: s 216(1) and s 216(2) of the Companies Act 1967; ss 125(1)(f), 125(1)(i), and s 125(3) of the Insolvency, Restructuring and Dissolution Act 2018
- Related Earlier Decision: Oon Swee Gek and others v Violet Oon Inc Pte Ltd and others and other matter [2024] SGHC 13 (“Violet Oon (Merits)”)
- Judgment Length: 25 pages; 6,221 words
Summary
This case is a supplementary decision in a long-running family-company dispute that had already been determined on the merits in Violet Oon (Merits). In the earlier judgment, the High Court found that the second defendant had procured a shareholders’ agreement through duress and undue influence, and that the resulting conduct amounted to commercial unfairness engaging the oppression remedy under s 216(1) of the Companies Act (CA 1967). The court ordered a buy-out remedy under s 216(2), requiring the second defendant’s shareholding (held via a wholly-owned corporate vehicle, the third defendant) to be sold to the claimants.
The present supplementary judgment addresses the remaining practical issues after the buy-out order: (1) the terms governing an independent valuation of the shares for the compulsory sale, including what “fair value” (equated to “equitable value”) means and what adjustments should or should not be made; and (2) the incidence and quantum of costs for the oppression action (OC 301) and the alternative winding-up application (CWU 195). The court also clarifies the scope of the valuation exercise, including the relevance of post-valuation events and the treatment of matters that were already decided as “functus officio”.
What Were the Facts of This Case?
The claimants are family members and co-founders of Violet Oon Inc Pte Ltd (“the Company”). Together, they held and controlled 50% of the Company’s shares. The second defendant acquired the other 50% shareholding in 2014 pursuant to a shareholders’ agreement negotiated with the claimants (the “2014 SHA”). Although the 50% interest was initially held through another wholly-owned corporate vehicle, it was later transferred to the third defendant, Group MMM Pte Ltd, of which the second defendant is the sole shareholder, director, and Chief Executive Officer.
Over time, the relationship between the claimants and the second defendant deteriorated. The dispute crystallised into two legal actions. The first was HC/OC 301/2022 (“OC 301”), an oppression action under s 216 of the CA 1967. In OC 301, the claimants sought to set aside agreements concluded in 2019 (the “2019 Agreements”) on the basis that they were procured through duress and undue influence. They also sought a buy-out order requiring the third defendant to sell its shares to the claimants.
In the alternative, the claimants brought HC/CWU 195/2022 (“CWU 195”), seeking a winding-up remedy if they could not obtain the buy-out in OC 301. Notably, the Company was a nominal party in both proceedings and was absent and unrepresented throughout the trial. Accordingly, the substantive contest was between the claimants and the second and third defendants.
After a nine-day trial, the court in Violet Oon (Merits) allowed the claimants’ oppression claims and ordered the third defendant to sell its shareholding to the claimants. The court made no orders on CWU 195, because the buy-out remedy was granted. The supplementary judgment therefore arises from what remained unresolved after the merits decision: the valuation mechanics for the compulsory sale and the costs consequences for both OC 301 and CWU 195.
What Were the Key Legal Issues?
The supplementary judgment focused on two main clusters of issues. The first cluster concerned the independent valuation of the shares for the court-ordered sale. The court had to decide what factors a valuer may take into account when determining the “fair value” of the Company’s shares, and specifically whether the valuation should incorporate (a) a discount for lack of marketability; and (b) a premium reflecting the control that the claimants would acquire upon completion of the buy-out.
The second cluster concerned costs. The court had to determine (a) what the relevant “event” was for costs purposes in OC 301 and CWU 195; and (b) the appropriate quantum of costs to award, applying the costs framework in the Supreme Court Practice Directions 2021, including Appendix G, which sets out guidelines for party-and-party costs for trials of commercial matters.
How Did the Court Analyse the Issues?
1. The valuation framework: “fair value” as “equitable value”. The court began by setting the agreed background for the valuation. In Violet Oon (Merits), the court had accepted that the shares had to be sold at “fair value” and ordered the sale on that basis. For the supplementary proceedings, the parties agreed that “fair value” should be understood as “equitable value” between a known buyer and a known seller. The court indicated that, where appropriate, the valuer may align the approach with the concept in the International Valuation Standards (effective 31 January 2022), describing equitable value as an estimated price for transfer between identified knowledgeable and willing parties reflecting their respective interests, and noting that this is broader than “market value”.
2. Marketability discount: whether lack of marketability may be factored in. The court then addressed Issue 1(A): whether the valuation may include a discount for the lack of marketability of the Company’s shares. Although the extract provided does not reproduce the full reasoning, the structure of the decision indicates that the court considered the valuation purpose in a compulsory sale context. The oppression remedy under s 216(2) is designed to provide an equitable resolution to the unfairness found on the merits. In that setting, the valuation exercise is not merely a hypothetical market transaction; it is a court-supervised mechanism to translate the statutory remedy into a monetary equivalent.
Accordingly, the court’s analysis would have required balancing two competing valuation principles: (i) the economic reality that private company shares are typically less liquid than publicly traded shares; and (ii) the risk that an unjustified marketability discount could under-compensate the oppressed minority (or, here, the claimants who are the beneficiaries of the oppression remedy) relative to the “equitable value” concept. The court’s approach, as signposted by the agreed framework, would have been to ensure that any discount is consistent with the identified buyer/identified seller premise and the equitable nature of the valuation.
3. Control premium: whether the valuation should reflect the acquisition of control. Issue 1(B) concerned whether the valuation should include a premium for the control of the Company that the claimants would acquire. This issue is closely linked to the nature of the buy-out order: the claimants were not buying a passive minority interest but were acquiring the shares necessary to take control (or at least to consolidate control) of the Company following the compulsory sale. A control premium may be justified where the buyer obtains additional governance rights and the ability to influence corporate direction, strategy, and value creation.
At the same time, the court would have had to consider whether the oppression remedy’s equitable objective requires the valuation to reflect the value of control that is being transferred as a consequence of the defendants’ oppressive conduct. In other words, the court would likely have been cautious not to allow valuation methodology to reintroduce the unfairness that the oppression finding had already addressed. The equitable value concept, again, is central: it is not necessarily identical to a market price, and it should reflect the interests of the identified parties in the context of the court-ordered transaction.
4. Scope of valuation: post-valuation circumstances and “functus officio”. The court also addressed the relevance of post-valuation circumstances. The parties had initially debated whether the valuer should consider events after the valuation date, including (a) the extension of the Company’s lease at Jewel Changi Airport; (b) uncertainty about whether the ION outlet would continue after its lease expires in 2025; and (c) whether the ION outlet might have to close for renovation works, requiring capital expenditure. By the time of the oral hearing, the parties agreed that the valuer should be limited to facts reasonably foreseeable as at the valuation date, with the valuer determining whether the relevant facts were or were not reasonably foreseeable.
In addition, the court dealt with an issue on which it had already ruled in Violet Oon (Merits): whether the valuation should be based on the Company paying licence fees to the first claimant for use of her name. The parties agreed that the court was functus officio on that point because the earlier judgment had already held that the valuation should proceed on the basis that the Company has the right to use and exploit the first claimant’s name without payment of a licence fee to her. This illustrates the court’s commitment to preventing re-litigation of matters already decided, while still allowing the valuation to be completed on the correct legal footing.
5. “But for” adjustments and remedial alignment. Finally, the court considered whether the valuation should be adjusted to account for what the value of the shares would have been “but for” the oppressive conduct. The claimants indicated they were content to make submissions to the valuer on this point or pursue other causes of action, including seeking leave to institute a derivative action or authorising an action against the third defendant for moneys allegedly paid pursuant to the set-aside 2019 Agreements. This reflects a practical remedial approach: the valuation is one component of the overall resolution, but it does not necessarily exhaust all potential monetary consequences of the oppressive conduct.
6. Costs: identifying the “event” and applying Appendix G. The second major part of the supplementary judgment concerned costs. The court had to decide what the “event” was in OC 301 and CWU 195 for costs purposes. In oppression litigation with an alternative winding-up application, the “event” can be contested because the winding-up may be dismissed or left without orders once the primary buy-out remedy is granted. The court’s analysis would have required determining how the procedural outcome in each action should translate into costs consequences.
Once the event was identified, the court then determined the appropriate quantum of costs. The judgment references Appendix G of the Supreme Court Practice Directions 2021, which provides guidelines for party-and-party costs for trials of commercial matters. The court’s task was to apply those guidelines to the circumstances of the case, including the length and complexity of the trial, the nature of the claims, and the extent to which each action succeeded or failed. The extract indicates that the parties had been unable to agree on costs, prompting the court to determine both incidence and quantum.
What Was the Outcome?
The court’s supplementary orders addressed the remaining unresolved matters necessary to implement the buy-out remedy. It decided the terms governing the independent valuation of the third defendant’s shares, including the permissible valuation factors and the treatment of marketability discount and control premium, as well as the scope of the valuer’s consideration of post-valuation circumstances and the “functus officio” constraint on issues already determined in Violet Oon (Merits).
In addition, the court made orders on costs for OC 301 and CWU 195. It determined the relevant “event” for costs purposes and awarded costs in an amount consistent with the Supreme Court Practice Directions 2021, Appendix G framework. Practically, the decision enabled the valuation process to proceed to completion and clarified the financial consequences of the litigation for the parties.
Why Does This Case Matter?
This case is significant for practitioners because it demonstrates how the oppression remedy under s 216(2) can be operationalised through a court-ordered share sale, and how valuation methodology becomes a legal question rather than a purely expert-driven exercise. The court’s insistence on an “equitable value” framework between identified knowledgeable and willing parties provides a useful conceptual anchor for valuers and litigators in compulsory sale contexts.
Second, the judgment is a practical guide on how valuation disputes are narrowed after a merits decision. The court’s approach to “functus officio” confirms that valuation cannot be used as a backdoor to revisit legal determinations already made on the merits (such as the licence-fee issue). Similarly, the court’s treatment of post-valuation circumstances—limiting the valuer to reasonably foreseeable facts as at the valuation date—helps prevent speculative or opportunistic valuation adjustments.
Third, the costs analysis is also instructive. By applying the Supreme Court Practice Directions 2021, Appendix G, the court provides a structured approach to costs in commercial trials involving oppression and alternative winding-up relief. For lawyers, this reduces uncertainty about how costs will be assessed when the primary remedy is granted and the alternative application receives no substantive orders.
Legislation Referenced
- Companies Act 1967 (2020 Rev Ed), s 216(1) and s 216(2) [CDN] [SSO]
- Insolvency, Restructuring and Dissolution Act 2018 (2020 Rev Ed), ss 125(1)(f), 125(1)(i), and 125(3) [CDN] [SSO]
Cases Cited
- (Not provided in the supplied extract.)
Source Documents
This article analyses [2024] SGHC 170 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.